MultiplexDX obtained a €3.5m grant from EU

MultiplexDX (Pavol Čekan and Vladimír Wolf) obtained a €3.5m grant from the European Innovation Council that has allocated €278m to 75 European and global startups. MultiplexDX develops personalized molecular diagnostics for breast cancer. It will use the money for clinical validation to persuade oncologists to offer their diagnostics to their patients.

(etrend.sk)

Táto správa je z Ekonomiky DNES, denného prehľadu najdôležitejších ekonomických správ zo Slovenska.

This news is from the Slovak Business News TODAY, one-page summary of all the important Slovak business news.

Copyright  © 1994 - 2019    Symsite Research         All rights reserved.